Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to ETFdb.com. Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience
Etfdb logo
  • ETF
  • XHS
    Pricing Data
    $53.00
    Change: $0.26 (0.0%)
    Time: 12/09/16
    Previous Close: $52.74
  • Category
  • Health & Biotech Equities
Last Updated:

Profile

Vitals

Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $47.38
  • 52 Week Hi: $60.06
  • AUM: $105.5 M
  • Shares: 2.0 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 29,409
  • 3 Month Avg. Volume: 21,746

Alternative ETFs in the Health & Biotech Equities Category

Sign Up for Pro to Unlock Data Sign Up
Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest
Largest (AUM)
Most Liquid (Volume)
Top YTD Performer

Analyst Report

This ETF offers targeted exposure to health care services companies, a narrow slice of the U.S. economy that includes health care service providers, managed health care firms, health care facilities, and health care distributors. The health care sector may be appealing to investors looking to add stability to their portfolio, and this corner of the market is also capable of delivering solid distribution yields to investors. Given the relatively narrow focus, this fund probably is of little use to investors building a long-term, buy-and-hold portfolio; it will be more useful to those looking to establish a tactical tilt within their portfolios. There are a couple aspects of XHS that make this product noteworthy and unique from competing funds. First, the underlying index is equal weighted, a feature that results in a well balanced portfolio. That should be appealing to investors for a number of reasons, including the potential to avoid market cap weighting methodologies that some believe contain potential drawbacks to long-term performance. There are a number of broad-based funds in the Health & Biotech ETFdb Category that offer similar exposure to this corner of the market. For investors looking to achieve targeted exposure to health care services stocks, XHS is an efficient way to tap into this corner of the market.

Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for XHS on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

XHS Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity C+ n/a
Expenses A- n/a
Performance
Volatility
Dividend
Concentration

Knowledge Centers

XHS In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb Category.

XHS Holdings

Filings Data as of: Dec 04, 2016
Sign Up for Pro to Unlock Data Sign Up

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb Category.

Number of Holdings
Rank:
55
Category Low
Category High
% Assets in Top 10
Rank:
26.68%
Category Low
Category High

Asset Allocation

Asset Percentage
U.S. Stocks 99.29%
International Stocks 0.49%
U.S. Bonds 0.0%
International Bonds 0.0%
Preferred Stock 0.0%
Convertibles 0.0%
Cash 0.0%
Other 0.21%

Sector Breakdown

Sector Percentage
Health Care 88.84%
Industrials 5.88%
Technology 4.57%
Financial Services 0.49%
Real Estate 0.0%
Consumer Defensive 0.0%
Consumer Cyclical 0.0%
Basic Materials 0.0%
Energy 0.0%
Communication Services 0.0%
Utilities 0.0%

Market Cap Breakdown

Market Cap Percentage
Giant 2.7%
Large 18.77%
Medium 24.81%
Small 39.19%
Micro 14.32%

Region Breakdown

Region Percentage
U.S. 99.29%
Latin America 0.49%
Middle East 0.0%
Japan 0.0%
Australia 0.0%
Africa 0.0%
Europe 0.0%
Asia (Developed) 0.0%
Canada 0.0%
Asia (Emerging) 0.0%

Market Tier Breakdown

Region Percentage
Developed 99.79%
Emerging 0.0%

Country Breakdown

Country Percentage
United States 99.29%
Puerto Rico 0.49%
Other 0.22%

XHS Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up

Expenses Ratio Analysis

ETF Average
0.573%
ETF Wtd. Average
0.25%
Category Average
0.48%
Expense Ratio
Rank:
0.35%
Category Low
Category High

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:

XHS Performance

This section shows how this ETF has performed relative to its peer group ETFdb Category.

1 Week Return
Rank:
2.22%
Category Low
Category High
4 Week Return
Rank:
6.36%
Category Low
Category High
13 Week Return
Rank:
-2.78%
Category Low
Category High
26 Week Return
Rank:
-8.72%
Category Low
Category High
Year to Date Return
Rank:
-7.46%
Category Low
Category High
1 Year Return
Rank:
-7.77%
Category Low
Category High
3 Year Return
Rank:
19.40%
Category Low
Category High
5 Year Return
Rank:
106.85%
Category Low
Category High

Brought to You by Mitre Media


Charts

The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of XHS relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

XHS Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
P/E Ratio
Rank:
15.87
Category Low
Category High

As of Aug 25 2016

XHS Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
Dividend
$0.04
Dividend Date
2016-09-16
Annual Dividend Rate
$0.14
Annual Dividend Yield
Rank:
0.27%
Category Low
Category High

As of Aug 25, 2016

XHS Technicals

Sign Up for Pro to Unlock Data Sign Up

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb Category.

5 Day Volatility
Rank:
200.69%
Category Low
Category High
20 Day Volatility
Rank:
14.56%
Category Low
Category High
50 Day Volatility
Rank:
20.25%
Category Low
Category High
200 Day Volatility
Rank:
17.67%
Category Low
Category High
Beta
Rank:
0.9
Category Low
Category High
Standard Deviation
Rank:
2.76%
Category Low
Category High

Technicals

  • 20 Day MA: $51.92
  • 60 Day MA: $52.62
  • MACD 15 Period: 0.86
  • MACD 100 Period: -1.07
  • Williams % Range 10 Day: 3.03
  • Williams % Range 20 Day: 1.10
  • RSI 10 Day: 64
  • RSI 20 Day: 55
  • RSI 30 Day: 51
  • Ultimate Oscillator: 53

Bollinger Brands

  • Lower Bollinger (10 Day): $51.69
  • Upper Bollinger (10 Day): $52.81
  • Lower Bollinger (20 Day): $50.61
  • Upper Bollinger (20 Day): $53.16
  • Lower Bollinger (30 Day): $48.32
  • Upper Bollinger (30 Day): $53.75

Support & Resistance

  • Support Level 1: $52.82
  • Support Level 2: $52.64
  • Resistance Level 1: $53.11
  • Resistance Level 2: $53.22

Stochastic

  • Stochastic Oscillator %D (1 Day): 72.59
  • Stochastic Oscillator %D (5 Day): 77.55
  • Stochastic Oscillator %K (1 Day): 60.28
  • Stochastic Oscillator %K (5 Day): 65.70

Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.